# OnCo record jabez-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/jabez-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "jabez-biosciences" ;
  schema:name "Jabez Biosciences"@en ;
  schema:alternateName "Jabez Bioscience"@en ;
  schema:description "Jabez Biosciences makes JBZ-001, a tablet that blocks an enzyme cancer cells need to build new DNA and RNA building blocks. It is in a first trial in people with advanced solid tumours and non-Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/companies/jabez-biosciences/>, <https://www.jabezbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.jabezbio.com/>, <https://www.jabezbio.com/2025/04/03/jabez-biosciences-inc-announces-first-patient-dosed-in-phase-1-oncology-clinical-study-of-jbz-001/>, <https://clinicaltrials.gov/study/NCT06801002> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/metabolic-therapy/> .